Kaijie Zhou, Licheng Zhou, Jean C. Tien, Weixue Huang, Wenyan Liu, Xinyu Sun et al. Discovery and preclinical evaluation of ZLC853 as a potential clinical candidate covalently targeting CDK12/13 kinases. // Acta Pharmaceutica Sinica B. – 2026. – DOI: 10.1016/j.apsb.2026.07.041. – URL: https://doi.org/10.1016/j.apsb.2026.07.041
Kaijie Zhou, Licheng Zhou, Jean C. Tien, Weixue Huang, Wenyan Liu, Xinyu Sun, Bohai Fan, Xin Huang, Jun Wang, Yu Chang, Jianzhang Yang, Yue Yin, Chen Su, Qingrun Li, Rahul Mannan, Somnath Mahapatra, Yunhui Cheng, Abigail J. Todd, Christina E. Wheeler, Shuqin Li, Yang Zhou, Xiaomei Ren, George Xiaoju Wang, Zhen Wang, Arul M. Chinnaiyan, & Ke Ding (2026). Discovery and preclinical evaluation of ZLC853 as a potential clinical candidate covalently targeting CDK12/13 kinases. Acta Pharmaceutica Sinica B. https://doi.org/10.1016/j.apsb.2026.07.041
Kaijie Zhou, et al. “Discovery and preclinical evaluation of ZLC853 as a potential clinical candidate covalently targeting CDK12/13 kinases.” Acta Pharmaceutica Sinica B, 2026. doi:10.1016/j.apsb.2026.07.041.
@article{Zhou2026,
title = {Discovery and preclinical evaluation of ZLC853 as a potential clinical candidate covalently targeting CDK12/13 kinases},
author = {Zhou, Kaijie and Zhou, Licheng and Tien, Jean C. and Huang, Weixue and Liu, Wenyan and Sun, Xinyu and Fan, Bohai and Huang, Xin and Wang, Jun and Chang, Yu and Yang, Jianzhang and Yin, Yue and Su, Chen and Li, Qingrun and Mannan, Rahul and Mahapatra, Somnath and Cheng, Yunhui and Todd, Abigail J. and Wheeler, Christina E. and Li, Shuqin and Zhou, Yang and Ren, Xiaomei and Wang, George Xiaoju and Wang, Zhen and Chinnaiyan, Arul M. and Ding, Ke},
journal = {Acta Pharmaceutica Sinica B},
year = {2026},
doi = {10.1016/j.apsb.2026.07.041},
url = {https://doi.org/10.1016/j.apsb.2026.07.041}
}